Editorial: Synthetic peptide vaccine platforms targeting tumor-specific antigens: advances and challenges.

MLA

Rubsamen, Reid M., and Andrew E. Sloan. “Editorial: Synthetic Peptide Vaccine Platforms Targeting Tumor-Specific Antigens: Advances and Challenges.” Frontiers in Pharmacology, Mar. 2024, pp. 1–2. EBSCOhost, https://doi.org/10.3389/fphar.2024.1363282.

APA

Rubsamen, R. M., & Sloan, A. E. (2024). Editorial: Synthetic peptide vaccine platforms targeting tumor-specific antigens: advances and challenges. Frontiers in Pharmacology, 1–2. https://doi.org/10.3389/fphar.2024.1363282

Chicago

Rubsamen, Reid M., and Andrew E. Sloan. 2024. “Editorial: Synthetic Peptide Vaccine Platforms Targeting Tumor-Specific Antigens: Advances and Challenges.” Frontiers in Pharmacology, March, 1–2. doi:10.3389/fphar.2024.1363282.